Jason N. Butler
Stock Analyst at Citizens
(1.88)
# 3,210
Out of 5,154 analysts
16
Total ratings
40%
Success rate
-4.33%
Average return
Main Sectors:
Stocks Rated by Jason N. Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GHRS GH Research | Maintains: Market Outperform | $39 → $42 | $15.93 | +163.65% | 1 | Mar 6, 2026 | |
| ARGX argenx SE | Maintains: Market Outperform | $925 → $944 | $717.79 | +31.51% | 1 | Feb 27, 2026 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Market Outperform | $8 → $10 | $3.50 | +185.71% | 1 | Feb 26, 2026 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Market Outperform | $34 → $35 | $22.16 | +57.94% | 3 | Feb 26, 2026 | |
| ACHV Achieve Life Sciences | Initiates: Market Outperform | $19 | $4.27 | +344.96% | 1 | Nov 25, 2025 | |
| RAPP Rapport Therapeutics | Maintains: Market Outperform | $77 → $80 | $30.24 | +164.55% | 1 | Nov 7, 2025 | |
| WULF TeraWulf | Maintains: Market Outperform | $18 → $22 | $13.75 | +60.00% | 1 | Oct 29, 2025 | |
| RZLT Rezolute | Maintains: Market Outperform | $9 → $17 | $3.11 | +446.62% | 1 | Oct 29, 2025 | |
| ABVX ABIVAX Société Anonyme | Maintains: Market Outperform | $95 → $114 | $109.33 | +4.27% | 1 | Sep 25, 2025 | |
| CRMD CorMedix | Reiterates: Market Outperform | $22 | $6.46 | +240.56% | 1 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $78 | $60.41 | +29.12% | 1 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $6 → $8 | $3.32 | +140.96% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $19 → $18 | $8.98 | +100.45% | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $91 → $78 | $67.37 | +15.78% | 1 | Aug 6, 2025 |
GH Research
Mar 6, 2026
Maintains: Market Outperform
Price Target: $39 → $42
Current: $15.93
Upside: +163.65%
argenx SE
Feb 27, 2026
Maintains: Market Outperform
Price Target: $925 → $944
Current: $717.79
Upside: +31.51%
Ironwood Pharmaceuticals
Feb 26, 2026
Maintains: Market Outperform
Price Target: $8 → $10
Current: $3.50
Upside: +185.71%
ACADIA Pharmaceuticals
Feb 26, 2026
Maintains: Market Outperform
Price Target: $34 → $35
Current: $22.16
Upside: +57.94%
Achieve Life Sciences
Nov 25, 2025
Initiates: Market Outperform
Price Target: $19
Current: $4.27
Upside: +344.96%
Rapport Therapeutics
Nov 7, 2025
Maintains: Market Outperform
Price Target: $77 → $80
Current: $30.24
Upside: +164.55%
TeraWulf
Oct 29, 2025
Maintains: Market Outperform
Price Target: $18 → $22
Current: $13.75
Upside: +60.00%
Rezolute
Oct 29, 2025
Maintains: Market Outperform
Price Target: $9 → $17
Current: $3.11
Upside: +446.62%
ABIVAX Société Anonyme
Sep 25, 2025
Maintains: Market Outperform
Price Target: $95 → $114
Current: $109.33
Upside: +4.27%
CorMedix
Sep 9, 2025
Reiterates: Market Outperform
Price Target: $22
Current: $6.46
Upside: +240.56%
Sep 2, 2025
Reiterates: Market Outperform
Price Target: $78
Current: $60.41
Upside: +29.12%
Aug 19, 2025
Maintains: Market Outperform
Price Target: $6 → $8
Current: $3.32
Upside: +140.96%
Aug 13, 2025
Maintains: Market Outperform
Price Target: $19 → $18
Current: $8.98
Upside: +100.45%
Aug 6, 2025
Maintains: Market Outperform
Price Target: $91 → $78
Current: $67.37
Upside: +15.78%